MX2021014654A - Implante de mama biologico. - Google Patents

Implante de mama biologico.

Info

Publication number
MX2021014654A
MX2021014654A MX2021014654A MX2021014654A MX2021014654A MX 2021014654 A MX2021014654 A MX 2021014654A MX 2021014654 A MX2021014654 A MX 2021014654A MX 2021014654 A MX2021014654 A MX 2021014654A MX 2021014654 A MX2021014654 A MX 2021014654A
Authority
MX
Mexico
Prior art keywords
breast implant
biological breast
tissue products
tissue
biological
Prior art date
Application number
MX2021014654A
Other languages
English (en)
Spanish (es)
Inventor
Hui Xu
Alexandra Pastino
Carrie Fang
Original Assignee
Lifecell Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lifecell Corp filed Critical Lifecell Corp
Publication of MX2021014654A publication Critical patent/MX2021014654A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A61L27/3633—Extracellular matrix [ECM]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A61L27/3691—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by physical conditions of the treatment, e.g. applying a compressive force to the composition, pressure cycles, ultrasonic/sonication or microwave treatment, lyophilisation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/12—Mammary prostheses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3641—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the site of application in the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A61L27/3687—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by the use of chemical agents in the treatment, e.g. specific enzymes, detergents, capping agents, crosslinkers, anticalcification agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/56—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0002—Two-dimensional shapes, e.g. cross-sections
    • A61F2230/0004—Rounded shapes, e.g. with rounded corners
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2240/00—Manufacturing or designing of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2240/001—Designing or manufacturing processes
    • A61F2240/002—Designing or making customized prostheses
    • A61F2240/004—Using a positive or negative model, e.g. moulds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/04—Materials or treatment for tissue regeneration for mammary reconstruction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/40—Preparation and treatment of biological tissue for implantation, e.g. decellularisation, cross-linking

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Botany (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Dispersion Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Materials For Medical Uses (AREA)
  • Prostheses (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
MX2021014654A 2019-05-30 2020-05-29 Implante de mama biologico. MX2021014654A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962854678P 2019-05-30 2019-05-30
PCT/US2020/035223 WO2020243497A1 (en) 2019-05-30 2020-05-29 Biologic breast implant

Publications (1)

Publication Number Publication Date
MX2021014654A true MX2021014654A (es) 2022-03-11

Family

ID=71787079

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2021014654A MX2021014654A (es) 2019-05-30 2020-05-29 Implante de mama biologico.
MX2026004761A MX2026004761A (es) 2019-05-30 2021-11-29 Implante de mama biologico

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2026004761A MX2026004761A (es) 2019-05-30 2021-11-29 Implante de mama biologico

Country Status (9)

Country Link
US (2) US11633521B2 (cg-RX-API-DMAC7.html)
EP (2) EP3976127B1 (cg-RX-API-DMAC7.html)
JP (2) JP2022534110A (cg-RX-API-DMAC7.html)
AU (2) AU2020283895B2 (cg-RX-API-DMAC7.html)
BR (1) BR112021024043A2 (cg-RX-API-DMAC7.html)
CA (1) CA3142151A1 (cg-RX-API-DMAC7.html)
ES (1) ES3056561T3 (cg-RX-API-DMAC7.html)
MX (2) MX2021014654A (cg-RX-API-DMAC7.html)
WO (1) WO2020243497A1 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11246994B2 (en) 2017-10-19 2022-02-15 Lifecell Corporation Methods for introduction of flowable acellular tissue matrix products into a hand
JP7463273B2 (ja) 2017-10-19 2024-04-08 ライフセル コーポレーション 流動性無細胞組織マトリックス製品および製造方法
AU2020267589B2 (en) 2019-05-08 2024-01-04 Musculoskeletal Transplant Foundation Tissue derived porous matrices and methods for making and using same
EP3976127B1 (en) * 2019-05-30 2025-09-24 LifeCell Corporation Biologic breast implant
US20210308336A1 (en) * 2020-04-03 2021-10-07 Lifecell Corporation Adipose tissue matrix with tropoelastin
FR3165647A1 (fr) 2024-08-26 2026-02-27 Hugo Alberto Drago Prothèse universelle biologique de matrice dermique acellulaire (ADM) destinée à être utilisée dans des processus de reconstruction corporelle et méthode de fabrication

Family Cites Families (159)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1562244A (en) 1976-11-11 1980-03-05 Lock P M Wound dressing materials
US4569348A (en) 1980-02-22 1986-02-11 Velcro Usa Inc. Catheter tube holder strap
US4373519A (en) 1981-06-26 1983-02-15 Minnesota Mining And Manufacturing Company Composite wound dressing
US4582640A (en) 1982-03-08 1986-04-15 Collagen Corporation Injectable cross-linked collagen implant material
IL74715A0 (en) 1984-03-27 1985-06-30 Univ New Jersey Med Biodegradable matrix and methods for producing same
US4969912A (en) 1988-02-18 1990-11-13 Kelman Charles D Human collagen processing and autoimplant use
US4950483A (en) 1988-06-30 1990-08-21 Collagen Corporation Collagen wound healing matrices and process for their production
US5024841A (en) 1988-06-30 1991-06-18 Collagen Corporation Collagen wound healing matrices and process for their production
US4902508A (en) 1988-07-11 1990-02-20 Purdue Research Foundation Tissue graft composition
US4938763B1 (en) 1988-10-03 1995-07-04 Atrix Lab Inc Biodegradable in-situ forming implants and method of producing the same
WO1991006568A1 (en) 1988-11-07 1991-05-16 Synergen, Inc. High molecular weight human angiogenic factors
US5104409A (en) 1989-01-10 1992-04-14 Baker James L Mammary implant
JP2719671B2 (ja) 1989-07-11 1998-02-25 日本ゼオン株式会社 創傷被覆材
US5290558A (en) 1989-09-21 1994-03-01 Osteotech, Inc. Flowable demineralized bone powder composition and its use in bone repair
US5131850A (en) 1989-11-03 1992-07-21 Cryolife, Inc. Method for cryopreserving musculoskeletal tissues
US5104957A (en) 1990-02-28 1992-04-14 Autogenesis Technologies, Inc. Biologically compatible collagenous reaction product and articles useful as medical implants produced therefrom
US5336616A (en) 1990-09-12 1994-08-09 Lifecell Corporation Method for processing and preserving collagen-based tissues for transplantation
AU650045B2 (en) 1990-09-12 1994-06-09 Lifecell Corporation Method and apparatus for cryopreparation dry stabilization and rehydration of biological suspensions
US8067149B2 (en) 1990-09-12 2011-11-29 Lifecell Corporation Acellular dermal matrix and method of use thereof for grafting
US5231169A (en) 1990-10-17 1993-07-27 Norian Corporation Mineralized collagen
US5263971A (en) 1991-02-13 1993-11-23 Life Medical Sciences, Inc. Apparatus for the closure of wide skin defects by stretching of skin
US5254133A (en) 1991-04-24 1993-10-19 Seid Arnold S Surgical implantation device and related method of use
US5149331A (en) 1991-05-03 1992-09-22 Ariel Ferdman Method and device for wound closure
US5160313A (en) 1991-05-14 1992-11-03 Cryolife, Inc. Process for preparing tissue for transplantation
US5636643A (en) 1991-11-14 1997-06-10 Wake Forest University Wound treatment employing reduced pressure
US7198046B1 (en) 1991-11-14 2007-04-03 Wake Forest University Health Sciences Wound treatment employing reduced pressure
US5645081A (en) 1991-11-14 1997-07-08 Wake Forest University Method of treating tissue damage and apparatus for same
US5641518A (en) 1992-11-13 1997-06-24 Purdue Research Foundation Method of repairing bone tissue
US5275826A (en) 1992-11-13 1994-01-04 Purdue Research Foundation Fluidized intestinal submucosa and its use as an injectable tissue graft
US5437651A (en) 1993-09-01 1995-08-01 Research Medical, Inc. Medical suction apparatus
US5549584A (en) 1994-02-14 1996-08-27 The Kendall Company Apparatus for removing fluid from a wound
ATE265191T1 (de) 1994-03-14 2004-05-15 Cryolife Inc Herstellungsverfahren von gewebe zur implantation
US5489304A (en) 1994-04-19 1996-02-06 Brigham & Women's Hospital Method of skin regeneration using a collagen-glycosaminoglycan matrix and cultured epithelial autograft
US5906827A (en) 1994-06-03 1999-05-25 Creative Biomolecules, Inc. Matrix for the manufacture of autogenous replacement body parts
US5599852A (en) 1994-10-18 1997-02-04 Ethicon, Inc. Injectable microdispersions for soft tissue repair and augmentation
US5622867A (en) 1994-10-19 1997-04-22 Lifecell Corporation Prolonged preservation of blood platelets
US6485723B1 (en) 1995-02-10 2002-11-26 Purdue Research Foundation Enhanced submucosal tissue graft constructs
US5834232A (en) 1996-05-01 1998-11-10 Zymogenetics, Inc. Cross-linked gelatin gels and methods of making them
US6666892B2 (en) 1996-08-23 2003-12-23 Cook Biotech Incorporated Multi-formed collagenous biomaterial medical device
US6066325A (en) 1996-08-27 2000-05-23 Fusion Medical Technologies, Inc. Fragmented polymeric compositions and methods for their use
US6998418B1 (en) 1996-11-05 2006-02-14 Gp Medical, Inc. Acellular biological material chemically treated with genipin
WO1998019719A1 (en) 1996-11-05 1998-05-14 Purdue Research Foundation Myocardial graft constructs
AUPO599897A0 (en) 1997-04-03 1997-05-01 Vidal, Linus Clear collagen for facial implants
US5993844A (en) 1997-05-08 1999-11-30 Organogenesis, Inc. Chemical treatment, without detergents or enzymes, of tissue to form an acellular, collagenous matrix
US6135116A (en) 1997-07-28 2000-10-24 Kci Licensing, Inc. Therapeutic method for treating ulcers
US6613278B1 (en) 1998-11-13 2003-09-02 Regeneration Technologies, Inc. Tissue pooling process
GB9719520D0 (en) 1997-09-12 1997-11-19 Kci Medical Ltd Surgical drape and suction heads for wound treatment
US8668737B2 (en) 1997-10-10 2014-03-11 Senorx, Inc. Tissue marking implant
US6371992B1 (en) 1997-12-19 2002-04-16 The Regents Of The University Of California Acellular matrix grafts: preparation and use
US6071267A (en) 1998-02-06 2000-06-06 Kinetic Concepts, Inc. Medical patient fluid management interface system and method
US6326018B1 (en) 1998-02-27 2001-12-04 Musculoskeletal Transplant Foundation Flexible sheet of demineralized bone
US20030039678A1 (en) 1998-03-16 2003-02-27 Stone Kevin R. Xenograft bone matrix for orthopedic applications
US6179872B1 (en) 1998-03-17 2001-01-30 Tissue Engineering Biopolymer matt for use in tissue repair and reconstruction
US6432710B1 (en) 1998-05-22 2002-08-13 Isolagen Technologies, Inc. Compositions for regenerating tissue that has deteriorated, and methods for using such compositions
CA2332986C (en) 1998-05-26 2009-09-08 Lifecell Corporation Cryopreservation of human red blood cells
AU746973B2 (en) 1998-06-19 2002-05-09 Lifecell Corporation Particulate acellular tissue matrix
US6933326B1 (en) 1998-06-19 2005-08-23 Lifecell Coporation Particulate acellular tissue matrix
WO2000016822A1 (en) 1998-09-21 2000-03-30 The Brigham And Women's Hospital, Inc. Compositions and methods for tissue repair
US6565874B1 (en) 1998-10-28 2003-05-20 Atrix Laboratories Polymeric delivery formulations of leuprolide with improved efficacy
WO2000047114A1 (en) 1999-02-12 2000-08-17 Collagenesis, Inc. Injectable collagen-based delivery system for bone morphogenic proteins
US6856821B2 (en) 2000-05-26 2005-02-15 Kci Licensing, Inc. System for combined transcutaneous blood gas monitoring and vacuum assisted wound closure
US6599318B1 (en) 1999-11-30 2003-07-29 Shlomo Gabbay Implantable support apparatus and method of using same
US6576265B1 (en) 1999-12-22 2003-06-10 Acell, Inc. Tissue regenerative composition, method of making, and method of use thereof
EP1320390A2 (en) 2000-09-18 2003-06-25 Organogenesis Inc. Bioengineered flat sheet graft prosthesis and its use
IL139708A0 (en) 2000-11-15 2002-02-10 Amiel Gilad Process of decellularizing biological matrices and acellular biological matrices useful in tissue engineering
CA2365376C (en) 2000-12-21 2006-03-28 Ethicon, Inc. Use of reinforced foam implants with enhanced integrity for soft tissue repair and regeneration
US7070584B2 (en) 2001-02-20 2006-07-04 Kci Licensing, Inc. Biocompatible wound dressing
US7700819B2 (en) 2001-02-16 2010-04-20 Kci Licensing, Inc. Biocompatible wound dressing
US7763769B2 (en) 2001-02-16 2010-07-27 Kci Licensing, Inc. Biocompatible wound dressing
US7153518B2 (en) 2001-08-27 2006-12-26 Regeneration Technologies, Inc. Processed soft tissue for topical or internal application
US20030143207A1 (en) 2001-10-18 2003-07-31 Livesey Stephen A. Remodeling of tissues and organ
JP4489437B2 (ja) 2002-02-21 2010-06-23 エンセル,インコーポレイテッド 表面コーティングとしての固定化生物活性ヒドロゲルマトリックス
AU2003225516A1 (en) 2002-03-26 2003-10-08 Yissum Research Development Company Of The Hebrew University Of Jerusalem Responsive biomedical composites
US20030225347A1 (en) 2002-06-03 2003-12-04 Argenta Louis C. Directed tissue growth employing reduced pressure
US7498040B2 (en) 2005-10-12 2009-03-03 Lifenet Health Compositions for repair of defects in osseous tissues, and methods of making the same
US20040037735A1 (en) 2002-08-23 2004-02-26 Depaula Carl Alexander Allograft tissue purification process for cleaning bone
US6840960B2 (en) 2002-09-27 2005-01-11 Stephen K. Bubb Porous implant system and treatment method
US7402319B2 (en) 2002-09-27 2008-07-22 Board Of Regents, The University Of Texas System Cell-free tissue replacement for tissue engineering
US7824701B2 (en) 2002-10-18 2010-11-02 Ethicon, Inc. Biocompatible scaffold for ligament or tendon repair
US7115100B2 (en) 2002-11-15 2006-10-03 Ethicon, Inc. Tissue biopsy and processing device
US20040162613A1 (en) * 2003-02-06 2004-08-19 Thomas Roballey Cosmetic and reconstructive prosthesis containing a biologically compatible rupture indicator
FR2856305B1 (fr) 2003-06-19 2007-08-24 Inst Nat Sante Rech Med Protheses avec revetements biologiquement actifs
ES2569780T3 (es) 2003-06-27 2016-05-12 DePuy Synthes Products, Inc. Células posparto derivadas de tejido placentario y métodos de preparación y uso de las mismas
AU2004259019B2 (en) 2003-07-21 2010-09-23 Lifecell Corporation Acellular tissue matrices made from galactose alpha-1,3-galactose-deficient tissue
US6802861B1 (en) 2003-08-26 2004-10-12 Rsh-Gs Trust Structured breast implant
US7901461B2 (en) 2003-12-05 2011-03-08 Ethicon, Inc. Viable tissue repair implants and methods of use
JP2007529278A (ja) 2004-03-17 2007-10-25 レビビコア, インコーポレイテッド 機能的α1,3ガラクトシルトランスフェラーゼを欠く動物に由来する組織生成物
US20070190108A1 (en) * 2004-05-17 2007-08-16 Arindam Datta High performance reticulated elastomeric matrix preparation, properties, reinforcement, and use in surgical devices, tissue augmentation and/or tissue repair
KR100680134B1 (ko) 2004-06-10 2007-02-08 박우삼 무세포 진피를 주사가능하도록 입자 형태로 가공한 필러
US20060058892A1 (en) 2004-09-16 2006-03-16 Lesh Michael D Valved tissue augmentation implant
US20060073592A1 (en) 2004-10-06 2006-04-06 Wendell Sun Methods of storing tissue matrices
US7905826B2 (en) 2004-11-03 2011-03-15 Cook Incorporated Methods for modifying vascular vessel walls
DE102005002644A1 (de) 2005-01-19 2006-07-20 Schülke & Mayr GmbH Zusammensetzungen für die hygienische Händedesinfektion und die desinfizierende Händewaschung
WO2006116210A2 (en) 2005-04-25 2006-11-02 Bernstein Eric F Dermal fillers for biomedical applications in mammals and methods of using the same
ES2668551T3 (es) 2005-09-26 2018-05-18 Lifecell Corporation Composición seca de plaquetas
US7498041B2 (en) 2005-10-12 2009-03-03 Lifenet Health Composition for repair of defects in osseous tissues
JP5002805B2 (ja) 2005-10-14 2012-08-15 財団法人ヒューマンサイエンス振興財団 生物由来スキャフォールドの作製方法
US9456860B2 (en) 2006-03-14 2016-10-04 Kci Licensing, Inc. Bioresorbable foaming tissue dressing
US8029498B2 (en) 2006-03-14 2011-10-04 Kci Licensing Inc. System for percutaneously administering reduced pressure treatment using balloon dissection
US20070248575A1 (en) 2006-04-19 2007-10-25 Jerome Connor Bone graft composition
EP2021536B1 (en) 2006-04-24 2014-02-26 Coloplast A/S Non-woven structures produced by a non-toxic dry solvent spinning process
EP2015707B1 (en) 2006-05-09 2019-01-23 LifeCell Corporation Reinforced biological tissue
JP5050197B2 (ja) 2006-07-31 2012-10-17 財団法人ヒューマンサイエンス振興財団 生物由来スキャフォールドの作製方法
US20080114277A1 (en) 2006-11-09 2008-05-15 Archel Ambrosio Porous bioresorbable dressing conformable to a wound and methods of making same
WO2008134305A2 (en) 2007-04-26 2008-11-06 Johnson & Johnson Regenerative Therapeutics, Llc Tissue engineering devices and methods for luminal organs
US20080281418A1 (en) 2007-05-09 2008-11-13 Leigh Hunt Firestone Breast implant articles of multi-layered sheets of extracellular matrix or balled strips and pieces of extracellular matrix
US9034367B2 (en) 2007-05-10 2015-05-19 Cormatrix Cardiovascular, Inc. Articles for tissue regeneration with biodegradable polymer
US20080281419A1 (en) 2007-05-10 2008-11-13 Matheny Robert G Breast implants and compositions of extracellular matrix
WO2009006226A1 (en) 2007-06-29 2009-01-08 Kci Licensing Inc. Activation of bone and cartilage formation
DK3473260T3 (da) 2007-07-10 2020-12-21 Lifecell Corp Acellulære vævsmatrixs-sammensætninger til vævsreparation
US20090024224A1 (en) 2007-07-16 2009-01-22 Chen Silvia S Implantation of cartilage
US9782300B2 (en) 2008-02-01 2017-10-10 Kci Licensing, Inc. Fiber-microsphere bioresorbable composite scaffold for wound healing
AU2009246365B2 (en) 2008-05-13 2015-04-16 Kci Licensing, Inc. Catheter/filament style device and methods for treatment of wounds beneath the surface of the skin
AU2009256193B2 (en) 2008-06-06 2015-04-23 Lifecell Corporation Elastase treatment of tissue matrices
CA2840415C (en) 2008-06-25 2018-01-02 Kci Licensing, Inc. Absorbable, reduced-pressure manifolds and systems
EP2288396B1 (en) 2008-06-26 2016-06-15 KCI Licensing, Inc. Stimulation of cartilage formation using reduced pressure treatment and chondrocytes
US9050184B2 (en) 2008-08-13 2015-06-09 Allergan, Inc. Dual plane breast implant
EP2319548B1 (en) 2008-08-14 2016-06-01 KCI Licensing, Inc. Tissue scaffolds
US7927414B2 (en) 2008-09-05 2011-04-19 Ethicon, Inc. Method of manufacturing acellular matrix glue
AU2009316588B2 (en) 2008-11-21 2014-09-11 Stout Medical Group, L.P. Reinforced biologic material
CA2745903C (en) 2008-12-31 2018-07-17 Kci Licensing, Inc. System for providing fluid flow to nerve tissues
JP5628203B2 (ja) 2008-12-31 2014-11-19 ケーシーアイ ライセンシング インコーポレイテッド 組織の成長を刺激する流体フローを誘発するシステム
KR20110117129A (ko) 2008-12-31 2011-10-26 케이씨아이 라이센싱 인코포레이티드 조직에 유체 흐름을 제공하기 위한 시스템
CA2762212C (en) 2009-05-20 2015-12-29 Humacyte, Inc. Elastin for soft tissue augmentation
US8986377B2 (en) 2009-07-21 2015-03-24 Lifecell Corporation Graft materials for surgical breast procedures
CA2770490C (en) 2009-08-11 2024-04-16 The Johns Hopkins University Compositions and methods for implantation of processed adipose tissue and processed adipose tissue products
US20110093069A1 (en) 2009-10-16 2011-04-21 Allergan, Inc. Implants and methdos for manufacturing same
CN102711859B (zh) 2010-01-22 2016-02-24 凯希特许有限公司 用负压伤口疗法滴注发泡流体的器件、系统及方法
US8632512B2 (en) 2010-04-09 2014-01-21 Kci Licensing, Inc. Apparatuses, methods, and compositions for the treatment and prophylaxis of chronic wounds
AU2011276246B2 (en) 2010-07-08 2014-12-04 Lifecell Corporation Method for shaping tissue matrices
US20120040013A1 (en) 2010-08-10 2012-02-16 LifeCell Corporation. Regenerative Tissue Scaffolds
US20120232652A1 (en) 2011-03-07 2012-09-13 Rolando Mora Implant with a visual indicator of a barrier layer
BR112013026200A2 (pt) 2011-04-14 2019-08-27 Lifecell Corp método para preparar uma composição de matriz de tecido, e matriz de tecido
EP3851131A1 (en) * 2011-05-31 2021-07-21 LifeCell Corporation Adipose tissue matrices
EP3243533B1 (en) 2011-10-11 2020-06-17 Allergan Holdings France S.A.S. Threads of cross-linked hyaluronic acid and methods of use thereof
EP3622974A1 (en) 2011-11-10 2020-03-18 LifeCell Corporation Method for elimination of space through tissue approximation
US9532863B2 (en) 2011-12-20 2017-01-03 Lifecell Corporation Sheet tissue products
CA2859657C (en) 2011-12-20 2021-03-02 Lifecell Corporation Acellular tissue matrix particles and flowable products comprising them
BR112014026090A8 (pt) 2012-04-24 2019-08-27 Lifecell Corp composição de matriz tecidual apta a fluir
CA2871635A1 (en) 2012-04-24 2013-10-31 Lifecell Corporation Functionalized tissue matrices comprising chelated metals
CN105142572B (zh) 2013-01-30 2018-05-11 因普利特有限公司 人类可植入的组织扩张器
WO2015017500A1 (en) 2013-07-30 2015-02-05 Musculoskeletal Transplant Foundation Acellular soft tissue-derived matrices and methods for preparing same
US10722614B2 (en) 2013-09-25 2020-07-28 The University Of Kansas Decellularized hyaline cartilage powder for tissue scaffolds
US10092392B2 (en) 2014-05-16 2018-10-09 Allergan, Inc. Textured breast implant and methods of making same
WO2016022670A1 (en) * 2014-08-05 2016-02-11 The University Of Memphis Compositions and methods for enhancing healing and regeneration of bone and soft tissue
KR20170070008A (ko) * 2014-08-15 2017-06-21 더 존스 홉킨스 유니버시티 조직 복원용 복합 재료
EP3337423B1 (en) * 2015-08-17 2023-06-07 The Johns Hopkins University Fiber-hydrogel composite surgical meshes for tissue repair
GB201514788D0 (en) 2015-08-20 2015-10-07 Ecole Polytech Malleable scaffold material and uses thereof
CA3012849A1 (en) * 2016-02-08 2017-08-17 Lifecell Corporation Biologic breast implant
CN108697828A (zh) * 2016-02-11 2018-10-23 生命细胞公司 用于稳定包含胶原蛋白的组织产品防止酶降解的方法
ES2841427T3 (es) * 2016-07-05 2021-07-08 Lifecell Corp Matrices de tejido que incorporan múltiples tipos de tejido
US11123375B2 (en) * 2017-10-18 2021-09-21 Lifecell Corporation Methods of treating tissue voids following removal of implantable infusion ports using adipose tissue products
JP7297739B2 (ja) * 2017-10-18 2023-06-26 ライフセル コーポレーション 脂肪組織製品および製造方法
JP7463273B2 (ja) 2017-10-19 2024-04-08 ライフセル コーポレーション 流動性無細胞組織マトリックス製品および製造方法
US11246994B2 (en) 2017-10-19 2022-02-15 Lifecell Corporation Methods for introduction of flowable acellular tissue matrix products into a hand
US12151050B2 (en) * 2018-03-01 2024-11-26 Tepha, Inc. Medical devices containing compositions of poly(butylene succinate) and copolymers thereof
EP3790602A1 (en) * 2018-05-09 2021-03-17 The Johns Hopkins University Nanofiber-hydrogel composites for cell and tissue delivery
BR112021006348A2 (pt) * 2018-10-03 2021-07-06 Estab Labs Sa andaime para dispositivos médicos implantáveis e mé-todos de uso dos mesmos
EP3976127B1 (en) * 2019-05-30 2025-09-24 LifeCell Corporation Biologic breast implant

Also Published As

Publication number Publication date
MX2026004761A (es) 2026-06-01
CA3142151A1 (en) 2020-12-03
JP2022534110A (ja) 2022-07-27
AU2020283895B2 (en) 2026-07-02
EP3976127B1 (en) 2025-09-24
AU2026204492A1 (en) 2026-07-02
JP2026012665A (ja) 2026-01-27
EP3976127A1 (en) 2022-04-06
ES3056561T3 (en) 2026-02-23
EP4670751A2 (en) 2025-12-31
US11633521B2 (en) 2023-04-25
BR112021024043A2 (pt) 2022-02-08
US20200376160A1 (en) 2020-12-03
EP4670751A3 (en) 2026-03-18
US20230211048A1 (en) 2023-07-06
AU2020283895A1 (en) 2022-01-06
WO2020243497A1 (en) 2020-12-03

Similar Documents

Publication Publication Date Title
BR112021024043A2 (pt) Implante mamário biológico
DOP2022000172A (es) Compuestos de piperidina urea 4-metilsulfonil-sustituidos para el tratamiento de miocardiopatía dilatada (mcd)
MX2015017865A (es) Compuestos de pirimidinodiona contra estados cardiacos.
ECSP19076732A (es) Compuestos de heteroarilo bicíclicos 6–6 fusionados y su uso como inhibidores de lats
MX2021007158A (es) Heteroarilamidas utiles como inhibidores de kif18a.
BR112013030492A2 (pt) método para produzir um produto de tecido, produto de tecido produzido por um processo, método de tratamento, e sistema de tratamento
ECSP20046463A (es) Compuestos, composiciones y métodos para tratar enfermedades que involucren tejidos con enfermedades ácidas o hipóxicas
CO2019009423A2 (es) Inhibidores de mnk sustituidos con piperidina y métodos relacionados con los mismos
CO6390111A2 (es) Productos sanguíneos deshidratados por aspersión y métodos para elaborar los mismos
CO2020001927A2 (es) Método de producción de composiciones farmacéuticas que comprende el virus chikungunya inmunogénico chikv-delta5nsp3
MX392461B (es) Moduladores de receptores estrogénicos
EA201790693A1 (ru) Коррекция фигуры
MX2021004955A (es) Compuestos de pirimidinodiona biciclica sustituidos con tetrahidropirano (thp).
EA201890442A1 (ru) Получение фоторецепторов для лечения заболеваний сетчатки
MX2016016236A (es) Anticuerpos dirigidos contra cd127.
EP4295906A3 (en) Treatment of restenosis using temsirolimus
MA53995A (fr) Procédé de préparation de la revitalisation d'un tissu biocompatible
MX2012004897A (es) Metodo para preparar un tejido organico acelular de origen humano o animal para revitalizacion.
UY36399A (es) Compuestos aromáticos sustituidos y composiciones farmacéuticas para la autoreparación y regeneración del tejido
EP3527655A4 (en) MANUFACTURING METHOD FOR KIDNEY TISSUE
BR112022020003A2 (pt) Matriz de tecido adiposo com tropoelastina
CL2025001781A1 (es) Constructos de arni para inhibir expresión de ttr y métodos de uso de los mismos
RU2010125399A (ru) Способ лечения эпителиально-эндотелиальной дистрофии роговицы с помощью амниотической мембраны
EA201992258A1 (ru) Способы изготовления нирапариба
RU2014146616A (ru) Способы воздействия на экспрессию гена SNRPN